Literature DB >> 28663769

The role of CCK8 in the inhibition of glucose production.

Christopher J Ramnanan1, Dale S Edgerton1, Alan D Cherrington1.   

Abstract

A recent study suggested that a rise of cholecystokinin (CCK8) in the duodenum may bring about an inhibition of hepatic glucose production. The authors made use of the pancreatic clamp technique to characterize a gut-brain-liver signal generated by CCK8 that reduces glucose output by the liver. The pancreatic clamp conditions used created a situation in which the liver was markedly deficient in both insulin and glucagon. Although the data presented indicated that CCK8 can reduce glucose production, the authors do not establish a role for this inhibition in the reduction of glucose output seen in response to feeding. It must be remembered that in response to a meal the insulin level in the hepatic sinusoids rises markedly, as does the insulin level to which the brain is exposed. It therefore seems likely that either or both of these effects will drive the suppression of glucose production rather than any effect of CCK8. The importance of the CCK8 effect needs to be determined in the presence of elevated arterial and sinusoidal insulin before any conclusion can be drawn about its relevance.

Entities:  

Year:  2009        PMID: 28663769      PMCID: PMC5485841     

Source DB:  PubMed          Journal:  Cellscience        ISSN: 1742-8130


  23 in total

Review 1.  Gut hormones and the regulation of energy homeostasis.

Authors:  Kevin G Murphy; Stephen R Bloom
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 2.  Gastrointestinal regulation of food intake.

Authors:  David E Cummings; Joost Overduin
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Hypothalamic K(ATP) channels control hepatic glucose production.

Authors:  Alessandro Pocai; Tony K T Lam; Roger Gutierrez-Juarez; Silvana Obici; Gary J Schwartz; Joseph Bryan; Lydia Aguilar-Bryan; Luciano Rossetti
Journal:  Nature       Date:  2005-04-21       Impact factor: 49.962

4.  A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.

Authors:  D K Sindelar; J H Balcom; C A Chu; D W Neal; A D Cherrington
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

5.  Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa.

Authors:  H R Berthoud; L M Patterson
Journal:  Acta Anat (Basel)       Date:  1996

6.  The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans.

Authors:  D Matzinger; L Degen; J Drewe; J Meuli; R Duebendorfer; N Ruckstuhl; M D'Amato; L Rovati; C Beglinger
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

7.  Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.

Authors:  R J Lieverse; J B Jansen; A A Masclee; L C Rovati; C B Lamers
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

8.  Disposition of a mixed meal by the conscious dog.

Authors:  M C Moore; M J Pagliassotti; L L Swift; J Asher; J Murrell; D Neal; A D Cherrington
Journal:  Am J Physiol       Date:  1994-04

9.  Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans.

Authors:  R J Rushakoff; I D Goldfine; J D Carter; R A Liddle
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

Review 10.  Cholecystokinin.

Authors:  Rashmi Chandra; Rodger A Liddle
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2007-02       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.